BPMC - Blueprint Medicines Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BPMC is currently covered by 20 analysts with an average price target of $124.18. This is a potential upside of $17.93 (16.88%) from yesterday's end of day stock price of $106.25.

Blueprint Medicines Corp's activity chart (see below) currently has 172 price targets and 204 ratings on display. The stock rating distribution of BPMC is 69.15% BUY, 22.34% HOLD and 8.51% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.53% with an average time for these price targets to be met of 245.83 days.

Highest price target for BPMC is $135, Lowest price target is $43, average price target is $124.18.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 03-May-2024. First documented stock forecast 26-May-2015.

Currently out of the existing stock ratings of BPMC, 65 are a BUY (69.15%), 21 are a HOLD (22.34%), 8 are a SELL (8.51%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

76

$-31.19 (-29.10%)

65

3 days ago

10/12 (83.33%)

$-31.19 (-29.10%)

249

Buy

130

$22.81 (21.28%)

97

3 days ago

12/13 (92.31%)

$22.81 (21.28%)

82

Buy

125

$17.81 (16.62%)

114

3 days ago

2/12 (16.67%)

$17.81 (16.62%)

273

Buy

135

$27.81 (25.94%)

125

3 days ago

10/13 (76.92%)

$27.81 (25.94%)

283

Hold

75

$-32.19 (-30.03%)

70

3 days ago

8/10 (80%)

$-32.19 (-30.03%)

66

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BPMC (Blueprint Medicines Corp) average time for price targets to be met?

On average it took 245.83 days on average for the stock forecasts to be realized with a an average price target met ratio 77.53

Which analyst has the current highest performing score on BPMC (Blueprint Medicines Corp) with a proven track record?

RENI BENJAMIN

Which analyst has the most public recommendations on BPMC (Blueprint Medicines Corp)?

Reni Benjamin works at JMP and has 4 price targets and 4 ratings on BPMC

Which analyst is the currently most bullish on BPMC (Blueprint Medicines Corp)?

Andrew Fein with highest potential upside - $27.81

Which analyst is the currently most reserved on BPMC (Blueprint Medicines Corp)?

Andrew Berens with lowest potential downside - -$64.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?